Patents Assigned to Cytopeutics Sdn. Bhd.
  • Cell-based composition and use thereof for treatment of diabetes and associated metabolic disorders and for amelioration of insulin resistance in pre-diabetes
    Patent number: 11052119
    Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml. The cell-based composition is used in a form of medicament for treatment of diabetes and its associated metabolic disorders and complications.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: July 6, 2021
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • Cell-based composition and use thereof for treatment of vernal keratoconjunctivitis
    Patent number: 10828332
    Abstract: A method for the treatment of vernal keratoconjunctivitis in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: November 10, 2020
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze Piaw Chin, Kong Yong Then, Soon Keng Cheong
  • Cell-based composition and use thereof for treatment of acute stroke
    Patent number: 10278993
    Abstract: A method for the treatment of acute stroke in a subject by administering to said subject an effective amount of a cell-based composition containing a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from 0.01 million to 3.0 million cells/ml.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: May 7, 2019
    Assignee: Cytopeutics Sdn. Bhd.
    Inventors: Bernard Sze-Piaw Chin, Kong Yong Then, Soon Keng Cheong